1The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea
2National Cancer Control Institute, National Cancer Center, Goyang, Korea
3Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
4National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
Copyright © 2018 by the Korean Cancer Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
The Community of Population-Based Regional Cancer Registries
Chang-Hoon Kim (Busan Cancer Registry, Pusan National University Hospital), Cheol-In Yoo (Ulsan Caner Registry, Ulsan University Hospital), Jong-Hyock Park (Chungbuk Cancer Registry, Chungbuk National University Hospital), Hae-Sung Nam (Daejeon/Chungnam Cancer Registry, Chungnam National University and Hospital), Jung-Sik Huh (Jeju Cancer Registry, Jeju National University and Hospital), Jung-Ho Youm (Chonbuk Cancer Registry, Chonbuk National University Hospital), Eurah Goh (Kangwon Cancer Registry, Kangwon National University Hospital), Nam-Soo Hong (Daegu/Gyeongbuk Cancer Registry, Kyungpook National University Medical Center), Sun-Seog Kweon (Gwangju/Jeonnam Cancer Registry, Chonnam National University Hospital), Woo-Chul Kim (Incheon Cancer Registry, Inha University Hospital), Yune-Sik Kang (Gyeongnam Cancer Registry, Gyeongsang National University & Hospital)
Site/Type |
New cases |
Deaths |
Prevalent casesa) |
||||||
---|---|---|---|---|---|---|---|---|---|
Both sexes | Men | Women | Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 214,701 | 113,335 | 101,366 | 76,855 | 47,678 | 29,177 | 1,611,487 | 707,977 | 903,510 |
Lip, oral cavity, and pharynx | 3,309 | 2,390 | 919 | 1,170 | 884 | 286 | 21,827 | 14,656 | 7,171 |
Esophagus | 2,420 | 2,201 | 219 | 1,531 | 1,401 | 130 | 9,171 | 8,262 | 909 |
Stomach | 29,207 | 19,545 | 9,662 | 8,526 | 5,507 | 3,019 | 256,995 | 170,294 | 86,701 |
Colon and rectum | 26,790 | 15,911 | 10,879 | 8,301 | 4,698 | 3,603 | 220,653 | 131,579 | 89,074 |
Liver | 15,757 | 11,732 | 4,025 | 11,311 | 8,382 | 2,929 | 61,290 | 45,881 | 15,409 |
Gallbladderb) | 6,251 | 3,220 | 3,031 | 4,211 | 2,135 | 2,076 | 19,468 | 9,958 | 9,510 |
Pancreas | 6,342 | 3,359 | 2,983 | 5,439 | 2,908 | 2,531 | 9,517 | 5,031 | 4,486 |
Larynx | 1,146 | 1,079 | 67 | 344 | 319 | 25 | 10,049 | 9,452 | 597 |
Lung | 24,267 | 17,015 | 7,252 | 17,399 | 12,677 | 4,722 | 69,931 | 43,987 | 25,944 |
Breast | 19,219 | 77 | 19,142 | 2,354 | 16 | 2,338 | 179,081 | 686 | 178,395 |
Cervix uteri | 3,582 | - | 3,582 | 967 | - | 3,582 | 50,477 | - | 3,582 |
Corpus uteri | 2,404 | - | 2,404 | 319 | - | 2,404 | 20,859 | - | 2,404 |
Ovary | 2,443 | - | 2,443 | 1,055 | - | 2,443 | 18,112 | - | 2,443 |
Prostate | 10,212 | 10,212 | - | 1,700 | 1,700 | - | 69,438 | 69,438 | - |
Testis | 286 | 286 | - | 10 | 10 | - | 2,939 | 2,939 | - |
Kidney | 4,555 | 3,134 | 1,421 | 952 | 672 | 280 | 35,333 | 23,862 | 11,471 |
Bladder | 4,033 | 3,245 | 788 | 1,299 | 960 | 339 | 31,407 | 25,609 | 5,798 |
Brain and CNS | 1,776 | 958 | 818 | 1,266 | 674 | 592 | 10,349 | 5,334 | 5,015 |
Thyroid | 25,029 | 5,386 | 19,643 | 341 | 106 | 235 | 355,057 | 60,151 | 294,906 |
Hodgkin lymphoma | 271 | 174 | 97 | 49 | 33 | 16 | 2,571 | 1,623 | 948 |
Non-Hodgkin lymphoma | 4,396 | 2,519 | 1,877 | 1,771 | 1,026 | 745 | 27,478 | 15,622 | 11,856 |
Multiple myeloma | 1,455 | 762 | 693 | 889 | 466 | 423 | 5,330 | 2,779 | 2,551 |
Leukemia | 3,242 | 1,830 | 1,412 | 1,720 | 1,003 | 717 | 19,260 | 10,654 | 8,606 |
Other and ill defined | 16,309 | 8,300 | 8,009 | 3,931 | 2,101 | 1,830 | 104,895 | 50,180 | 54,715 |
CNS, central nervous system.
a) Limited-duration prevalent cases on January 1, 2016. These are patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,
b) Include the gallbladder and other/unspecified parts of the biliary tract.
Site/Type |
Crude incidence rate per 100,000 |
Age-standardized incidence rate per 100,000a) |
||||
---|---|---|---|---|---|---|
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 421.4 | 445.2 | 397.6 | 258.9 | 291.7 | 241.1 |
Lip, oral cavity, and pharynx | 6.5 | 9.4 | 3.6 | 4.1 | 6.2 | 2.2 |
Esophagus | 4.7 | 8.6 | 0.9 | 2.7 | 5.5 | 0.4 |
Stomach | 57.3 | 76.8 | 37.9 | 33.8 | 49.3 | 20.5 |
Colon and rectum | 52.6 | 62.5 | 42.7 | 30.4 | 40.2 | 22.2 |
Liver | 30.9 | 46.1 | 15.8 | 18.2 | 29.5 | 8.2 |
Gallbladderb) | 12.3 | 12.6 | 11.9 | 6.6 | 8.0 | 5.5 |
Pancreas | 12.4 | 13.2 | 11.7 | 7.0 | 8.5 | 5.7 |
Larynx | 2.2 | 4.2 | 0.3 | 1.3 | 2.7 | 0.1 |
Lung | 47.6 | 66.8 | 28.4 | 26.4 | 42.3 | 14.3 |
Breast | 37.7 | 0.3 | 75.1 | 24.8 | 0.2 | 49.2 |
Cervix uteri | 7.0 | - | 14.1 | 4.6 | - | 9.1 |
Corpus uteri | 4.7 | - | 9.4 | 3.1 | - | 6.1 |
Ovary | 4.8 | - | 9.6 | 3.2 | - | 6.3 |
Prostate | 20.0 | 40.1 | - | 11.2 | 25.4 | - |
Testis | 0.6 | 1.1 | - | 0.6 | 1.1 | - |
Kidney | 8.9 | 12.3 | 5.6 | 5.7 | 8.2 | 3.4 |
Bladder | 7.9 | 12.7 | 3.1 | 4.3 | 8.1 | 1.5 |
Brain and CNS | 3.5 | 3.8 | 3.2 | 2.8 | 3.1 | 2.4 |
Thyroid | 49.1 | 21.2 | 77.1 | 35.2 | 15.1 | 55.6 |
Hodgkin lymphoma | 0.5 | 0.7 | 0.4 | 0.5 | 0.6 | 0.4 |
Non-Hodgkin lymphoma | 8.6 | 9.9 | 7.4 | 5.9 | 7.2 | 4.6 |
Multiple myeloma | 2.9 | 3.0 | 2.7 | 1.6 | 1.9 | 1.4 |
Leukemia | 6.4 | 7.2 | 5.5 | 5.3 | 6.2 | 4.5 |
Other and ill defined | 32.0 | 32.6 | 31.4 | 19.7 | 22.6 | 17.4 |
Rank | Cause of death | No. of deaths (%) | Age-standardized death rate per 100,000a) |
---|---|---|---|
All causes | 275,895 (100) | 289.3 | |
1 | Cancer | 76,855 (27.9) | 82.0 |
2 | Heart disease | 28,326 (10.3) | 27.9 |
3 | Cerebrovascular disease | 24,455 (8.9) | 23.4 |
4 | Pneumonia | 14,718 (5.3) | 13.5 |
5 | Intentional self-harm (suicide) | 13,513 (4.9) | 18.3 |
6 | Diabetes mellitus | 10,558 (3.8) | 10.2 |
7 | Chronic lower respiratory diseases | 7,538 (2.7) | 6.8 |
8 | Disease of liver | 6,847 (2.5) | 8.1 |
9 | Transport accidents | 5,539 (2.0) | 7.6 |
10 | Hypertensive diseases | 5,050 (1.8) | 4.6 |
Others | 82,496 (29.9) | 87.1 |
Source: Mortality Data, 2015, Statistics Korea [8].
a) Age-adjusted using the Segi’s world standard population.
Site/Type |
Crude mortality rate per 100,000 |
Age-standardized mortality rate per 100,000a) |
||||
---|---|---|---|---|---|---|
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 150.8 | 187.3 | 114.4 | 82.0 | 119.6 | 54.6 |
Lip, oral cavity, and pharynx | 2.3 | 3.5 | 1.1 | 1.3 | 2.3 | 0.6 |
Esophagus | 3.0 | 5.5 | 0.5 | 1.6 | 3.4 | 0.2 |
Stomach | 16.7 | 21.6 | 11.8 | 8.9 | 13.8 | 5.4 |
Colon and rectum | 16.3 | 18.5 | 14.1 | 8.5 | 11.8 | 6.1 |
Liver | 22.2 | 32.9 | 11.5 | 12.6 | 20.9 | 5.4 |
Gallbladderb) | 8.3 | 8.4 | 8.1 | 4.2 | 5.3 | 3.4 |
Pancreas | 10.7 | 11.4 | 9.9 | 5.7 | 7.2 | 4.5 |
Larynx | 0.7 | 1.3 | 0.1 | 0.4 | 0.8 | 0.0 |
Lung | 34.1 | 49.8 | 18.5 | 17.9 | 31.2 | 8.2 |
Breast | 4.6 | 0.1 | 9.2 | 2.8 | 0.0 | 5.5 |
Cervix uteri | 1.9 | - | 3.8 | 1.1 | - | 2.0 |
Corpus uteri | 0.6 | - | 1.3 | 0.4 | - | 0.7 |
Ovary | 2.1 | - | 4.1 | 1.2 | - | 2.2 |
Prostate | 3.3 | 6.7 | - | 1.6 | 4.3 | - |
Testis | 0.0 | 0.0 | - | 0.0 | 0.0 | - |
Kidney | 1.9 | 2.6 | 1.1 | 1.0 | 1.7 | 0.5 |
Bladder | 2.5 | 3.8 | 1.3 | 1.2 | 2.4 | 0.5 |
Brain and CNS | 2.5 | 2.6 | 2.3 | 1.7 | 1.9 | 1.5 |
Thyroid | 0.7 | 0.4 | 0.9 | 0.3 | 0.3 | 0.4 |
Hodgkin lymphoma | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
Non-Hodgkin lymphoma | 3.5 | 4.0 | 2.9 | 2.0 | 2.7 | 1.4 |
Multiple myeloma | 1.7 | 1.8 | 1.7 | 1.0 | 1.2 | 0.8 |
Leukemia | 3.4 | 3.9 | 2.8 | 2.2 | 2.8 | 1.7 |
Other and ill defined | 7.7 | 8.3 | 7.2 | 4.3 | 5.5 | 3.5 |
Site/Type |
Both sexes |
Men |
Women |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1999 | 2015 |
Trend 1 |
Trend 2 |
1999 | 2015 |
Trend 1 |
Trend 2 |
1999 | 2015 |
Trend 1 |
Trend 2 |
|||||||
Year | APC | Year | APC | Year | APC | Year | APC | Year | APC | Year | APC | |||||||
All sites | 210.5 | 258.9 | 1999-2012 | 3.4a) | 2012-2015 | –6.1a) | 285.0 | 291.7 | 1999-2011 | 1.7a) | 2011-2015 | –3.6a) | 161.1 | 241.1 | 1999-2012 | 5.5a) | 2012-2015 | –7.5a) |
Lip, oral cavity, and pharynx | 3.6 | 4.1 | 1999-2015 | 0.5a) | - | - | 6.1 | 6.2 | 1999-2015 | –0.2 | - | - | 1.6 | 2.2 | 1999-2015 | 1.4a) | - | - |
Esophagus | 4.1 | 2.7 | 1999-2015 | –2.3a) | - | - | 8.8 | 5.5 | 1999-2015 | –2.7a) | - | - | 0.6 | 0.4 | 1999-2015 | –1.8a) | - | - |
Stomach | 43.6 | 33.8 | 1999-2011 | –0.1 | 2011-2015 | –5.7a) | 66.2 | 49.3 | 1999-2011 | –0.3 | 2011-2015 | –6.2a) | 26.7 | 20.5 | 1999-2011 | –0.3 | 2011-2015 | –5.1a) |
Colon and rectum | 20.4 | 30.4 | 1999-2010 | 6.0a) | 2010-2015 | –4.9a) | 26.2 | 40.2 | 1999-2010 | 6.5a) | 2010-2015 | –5.4a) | 16.4 | 22.2 | 1999-2010 | 4.9a) | 2010-2015 | –4.3a) |
Liver | 27.9 | 18.2 | 1999-2010 | –1.7a) | 2010-2015 | –4.6a) | 46.8 | 29.5 | 1999-2009 | –1.9a) | 2009-2015 | –4.2a) | 12.3 | 8.2 | 1999-2010 | –1.5a) | 2010-2015 | –5.0a) |
Gallbladderb) | 6.5 | 6.6 | 1999-2004 | 1.5 | 2004-2015 | –0.3 | 8.1 | 8.0 | 1999-2015 | 0.0 | - | - | 5.4 | 5.5 | 1999-2003 | 2.5 | 2003-2015 | –0.6a) |
Pancreas | 5.6 | 7.0 | 1999-2015 | 1.4a) | - | - | 7.8 | 8.5 | 1999-2015 | 0.7a) | - | - | 4.0 | 5.7 | 1999-2015 | 2.2a) | - | - |
Larynx | 2.3 | 1.3 | 1999-2015 | –3.6a) | - | - | 4.9 | 2.7 | 1999-2015 | –3.8a) | - | - | 0.4 | 0.1 | 1999-2007 | –8.9a) | 2007-2015 | –4.2a) |
Lung | 28.5 | 26.4 | 1999-2011 | 0.1 | 2011-2015 | –1.8a) | 51.4 | 42.3 | 1999-2005 | –0.1 | 2005-2015 | –1.6a) | 12.4 | 14.3 | 1999-2012 | 1.9a) | 2012-2015 | –2.0 |
Breast | 10.7 | 24.8 | 1999-2007 | 6.9a) | 2007-2015 | 4.0a) | 0.2 | 0.2 | 1999-2015 | –1.1 | - | - | 20.9 | 49.2 | 1999-2007 | 7.1a) | 2007-2015 | 4.1a) |
Cervix uteri | 8.5 | 4.6 | 1999-2015 | –3.9a) | - | - | - | - | - | - | - | - | 16.3 | 9.1 | 1999-2015 | –3.7a) | - | - |
Corpus uteri | 1.4 | 3.1 | 1999-2009 | 6.2a) | 2009-2015 | 3.1a) | - | - | - | - | - | - | 2.8 | 6.1 | 1999-2009 | 6.4a) | 2009-2015 | 3.3a) |
Ovary | 2.7 | 3.2 | 1999-2015 | 1.6a) | - | - | - | - | - | - | - | - | 5.0 | 6.3 | 1999-2015 | 1.8a) | - | - |
Prostate | 3.1 | 11.2 | 1999-2009 | 15.3a) | 2009-2015 | 0.3 | 8.4 | 25.4 | 1999-2009 | 13.7a) | 2009-2015 | –0.5 | - | - | - | - | - | - |
Testis | 0.3 | 0.6 | 1999-2015 | 4.9a) | - | - | 0.6 | 1.1 | 1999-2015 | 4.8a) | - | - | - | - | - | - | - | - |
Kidney | 3.0 | 5.7 | 1999-2009 | 6.7a) | 2009-2015 | 1.3a) | 4.5 | 8.2 | 1999-2010 | 6.1a) | 2010-2015 | 0.4 | 1.7 | 3.4 | 1999-2009 | 6.6a) | 2009-2015 | 1.1 |
Bladder | 4.6 | 4.3 | 1999-2004 | 2.4a) | 2004-2015 | –1.5a) | 9.0 | 8.1 | 1999-2005 | 1.5a) | 2005-2015 | –1.8a) | 1.6 | 1.5 | 1999-2003 | 2.6 | 2003-2015 | –1.7a) |
Brain and CNS | 2.9 | 2.8 | 1999-2008 | 1.3a) | 2008-2015 | –1.6a) | 3.2 | 3.1 | 1999-2009 | 1.2a) | 2009-2015 | –2.0 | 2.6 | 2.4 | 1999-2007 | 1.5 | 2007-2015 | –1.5a) |
Thyroid | 6.3 | 35.2 | 1999-2011 | 22.8a) | 2011-2015 | –13.3a) | 2.1 | 15.1 | 1999-2012 | 22.9a) | 2012-2015 | –16.9a) | 10.4 | 55.6 | 1999-2011 | 22.4a) | 2011-2015 | –14.4a) |
Hodgkin lymphoma | 0.2 | 0.5 | 1999-2015 | 4.1a) | - | - | 0.4 | 0.6 | 1999-2015 | 3.2a) | - | - | 0.1 | 0.4 | 1999-2015 | 5.3a) | - | - |
Non-Hodgkin lymphoma | 4.3 | 5.9 | 1999-2015 | 2.3a) | - | - | 5.6 | 7.2 | 1999-2015 | 1.9a) | - | - | 3.3 | 4.6 | 1999-2015 | 2.6a) | - | - |
Multiple myeloma | 1.0 | 1.6 | 1999-2015 | 3.3a) | - | - | 1.2 | 1.9 | 1999-2015 | 3.0a) | - | - | 0.8 | 1.4 | 1999-2015 | 3.5a) | - | - |
Leukemia | 4.7 | 5.3 | 1999-2015 | 0.9a) | - | - | 5.5 | 6.2 | 1999-2015 | 1.0a) | - | - | 3.9 | 4.5 | 1999-2015 | 0.7a) | - | - |
Other and ill defined | 14.4 | 19.7 | 1999-2008 | 3.5a) | 2008-2015 | 1.3a) | 18.1 | 22.6 | 1999-2015 | 1.8a) | - | - | 11.9 | 17.4 | 1999-2011 | 3.8a) | 2011-2015 | –0.3 |
Site/Type |
Both sexes |
Men |
Women |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1999 | 2015 |
Trend 1 |
Trend 2 |
1999 | 2015 |
Trend 1 |
Trend 2 |
1999 | 2015 |
Trend 1 |
Trend 2 |
|||||||
Year | APC | Year | APC | Year | APC | Year | APC | Year | APC | Year | APC | |||||||
All sites | 114.3 | 82.0 | 1999-2002 | 1.0 | 2002-2015 | –2.7a) | 176.6 | 119.6 | 1999-2002 | 1.2 | 2002-2015 | –3.1a) | 70.6 | 54.6 | 1999-2002 | 1.0 | 2002-2015 | –2.2a) |
Lip, oral cavity, and pharynx | 1.1 | 1.3 | 1999-2015 | –1.8a) | - | - | 2.0 | 2.3 | 1999-2015 | –2.1a) | - | - | 0.4 | 0.6 | 1999-2015 | –2.7a) | - | - |
Esophagus | 3.1 | 1.6 | 1999-2015 | –4.4a) | - | - | 6.8 | 3.4 | 1999-2015 | –4.6a) | - | - | 0.5 | 0.2 | 1999-2015 | –5.1a) | - | - |
Stomach | 23.8 | 8.9 | 1999-2003 | –3.3a) | 2003-2015 | –6.7a) | 36.9 | 13.8 | 1999-2003 | –2.6a) | 2003-2015 | –7.0a) | 14.6 | 5.4 | 1999-2003 | –4.4a) | 2003-2015 | –6.6a) |
Colon and rectum | 7.7 | 8.5 | 1999-2004 | 5.5a) | 2004-2015 | –1.3a) | 10.5 | 11.8 | 1999-2004 | 5.9a) | 2004-2015 | –1.0a) | 6.0 | 6.1 | 1999-2004 | 4.9a) | 2004-2015 | –1.8a) |
Liver | 20.4 | 12.6 | 1999-2002 | 0.8 | 2002-2015 | –3.6a) | 35.3 | 20.9 | 1999-2002 | –0.1 | 2002-2015 | –3.7a) | 8.3 | 5.4 | 1999-2002 | 2.9 | 2002-2015 | –3.7a) |
Gallbladderb) | 5.2 | 4.2 | 1999-2001 | 7.4 | 2001-2015 | –2.7a) | 6.8 | 5.3 | 1999-2001 | 6.2 | 2001-2015 | –2.8a) | 4.1 | 3.4 | 1999-2001 | 9.2 | 2001-2015 | –2.6a) |
Pancreas | 5.4 | 5.7 | 1999-2015 | 0.3a) | - | - | 7.6 | 7.2 | 1999-2015 | –0.4a) | - | - | 3.9 | 4.5 | 1999-2015 | 0.9a) | - | - |
Larynx | 1.6 | 0.4 | 1999-2015 | –9.5a) | - | - | 3.4 | 0.8 | 1999-2015 | –9.1a) | - | - | 0.4 | 0.0 | 1999-2010 | –15.4a) | 2010-2015 | –6.2 |
Lung | 22.4 | 17.9 | 1999-2002 | 1.8 | 2002-2015 | –2.1a) | 41.5 | 31.2 | 1999-2001 | 4.3 | 2001-2015 | –2.5a) | 9.4 | 8.2 | 1999-2002 | 2.3 | 2002-2015 | –1.5a) |
Breast | 2.2 | 2.8 | 1999-2015 | 1.4a) | - | - | 0.1 | 0.0 | 1999-2015 | –4.5a) | - | - | 4.2 | 5.5 | 1999-2015 | 1.7a) | - | - |
Cervix uteri | 1.4 | 1.1 | 1999-2003 | 8.4a) | 2003-2015 | –5.2a) | - | - | - | - | - | - | 2.6 | 2.0 | 1999-2003 | 7.8a) | 2003-2015 | –4.9a) |
Corpus uteri | 0.1 | 0.4 | 1999-2002 | 51.8a) | 2002-2015 | 3.4a) | - | - | - | - | - | - | 0.1 | 0.7 | 1999-2002 | 51.6a) | 2002-2015 | 3.8a) |
Ovary | 0.9 | 1.2 | 1999-2001 | 10.9 | 2001-2015 | 0.2 | - | - | - | - | - | - | 1.7 | 2.2 | 1999-2001 | 10.2 | 2001-2015 | 0.5 |
Prostate | 0.9 | 1.6 | 1999-2004 | 9.4a) | 2004-2015 | 0.4 | 2.6 | 4.3 | 1999-2002 | 17.5a) | 2002-2015 | 0.3 | - | - | - | - | - | - |
Testis | 0.0 | 0.0 | 1999-2015 | –2.5 | - | - | 0.1 | 0.0 | 1999-2015 | 2.9 | - | - | - | - | - | - | - | - |
Kidney | 1.1 | 1.0 | 1999-2015 | –0.1 | - | - | 1.8 | 1.7 | 1999-2015 | 0.0 | - | - | 0.5 | 0.5 | 1999-2015 | –0.8 | - | - |
Bladder | 1.3 | 1.2 | 1999-2015 | –1.3a) | - | - | 2.6 | 2.4 | 1999-2015 | –1.6a) | - | - | 0.5 | 0.5 | 1999-2001 | 10.8 | 2001-2015 | –1.9a) |
Brain and CNS | 1.9 | 1.7 | 1999-2002 | 4.4 | 2002-2015 | –2.0a) | 2.2 | 1.9 | 1999-2015 | –1.5a) | - | - | 1.6 | 1.5 | 1999-2015 | –1.4a) | - | - |
Thyroid | 0.4 | 0.3 | 1999-2003 | 7.0 | 2003-2015 | –4.2a) | 0.3 | 0.3 | 1999-2002 | 16.0 | 2002-2015 | –4.0a) | 0.5 | 0.4 | 1999-2004 | 4.3 | 2004-2015 | –4.7a) |
Hodgkin lymphoma | 0.0 | 0.1 | 1999-2003 | 29.6 | 2003-2015 | –0.2 | 0.0 | 0.1 | 1999-2004 | 19.2a) | 2004-2015 | –2.0 | 0.0 | 0.0 | 1999-2003 | 40.8 | 2003-2015 | 1.3 |
Non-Hodgkin lymphoma | 2.1 | 2.0 | 1999-2015 | –0.5a) | - | - | 3.0 | 2.7 | 1999-2015 | –0.8a) | - | - | 1.4 | 1.4 | 1999-2015 | –0.2 | - | - |
Multiple myeloma | 0.6 | 1.0 | 1999-2003 | 12.8a) | 2003-2015 | 0.8 | 0.8 | 1.2 | 1999-2003 | 10.9a) | 2003-2015 | 0.8 | 0.4 | 0.8 | 1999-2007 | 7.4a) | 2007-2015 | –1.1 |
Leukemia | 2.9 | 2.2 | 1999-2001 | 1.4 | 2001-2015 | –2.1a) | 3.5 | 2.8 | 1999-2015 | –1.7a) | - | - | 2.4 | 1.7 | 1999-2015 | –2.1a) | - | - |
Other and ill defined | 7.8 | 4.3 | 1999-2015 | –3.1a) | - | - | 9.0 | 5.5 | 1999-2009 | –0.6 | 2009-2015 | –6.8a) | 7.0 | 3.5 | 1999-2005 | –7.0a) | 2005-2015 | –2.2a) |
Site/Type |
Both sexes |
Men |
Women |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1993-1995 | 1996-2000 | 2001-2005 | 2006-2010 | 2011-2015 | Changea) | 1993-1995 | 1996-2000 | 2001-2005 | 2006-2010 | 2011-2015 | Changea) | 1993-1995 | 1996-2000 | 2001-2005 | 2006-2010 | 2011-2015 | Changea) | |
All sites | 41.2 | 44.0 | 54.0 | 65.2 | 70.7 | 29.5 | 31.7 | 35.3 | 45.4 | 56.5 | 62.8 | 31.1 | 53.4 | 55.3 | 64.2 | 74.2 | 78.4 | 25.0 |
Lip, oral cavity, and pharynx | 41.1 | 46.7 | 54.3 | 60.6 | 64.5 | 23.4 | 35.8 | 41.1 | 49.4 | 56.4 | 60.7 | 24.9 | 58.1 | 63.8 | 67.8 | 71.7 | 74.1 | 16.0 |
Esophagus | 12.7 | 15.2 | 21.4 | 29.6 | 36.0 | 23.3 | 11.8 | 14.3 | 20.6 | 29.0 | 35.7 | 23.9 | 23.7 | 24.2 | 29.7 | 36.5 | 39.3 | 15.6 |
Stomach | 42.8 | 46.6 | 57.8 | 68.1 | 75.4 | 32.6 | 43.0 | 46.9 | 58.4 | 68.7 | 76.3 | 33.3 | 42.6 | 46.0 | 56.5 | 66.7 | 73.7 | 31.1 |
Colon and rectum | 54.8 | 58.0 | 66.7 | 73.5 | 76.3 | 21.5 | 55.3 | 59.0 | 68.5 | 75.4 | 78.0 | 22.7 | 54.2 | 56.8 | 64.3 | 70.8 | 73.6 | 19.4 |
Liver | 10.7 | 13.2 | 20.4 | 28.1 | 33.6 | 22.9 | 9.9 | 12.9 | 20.3 | 28.1 | 34.1 | 24.2 | 13.6 | 14.2 | 20.9 | 28.1 | 32.2 | 18.6 |
Gallbladderb) | 17.3 | 19.7 | 23.1 | 26.8 | 29.1 | 11.8 | 16.6 | 20.3 | 23.5 | 27.7 | 30.2 | 13.6 | 18.0 | 19.1 | 22.7 | 25.9 | 28.0 | 10.0 |
Pancreas | 9.4 | 7.6 | 8.4 | 8.4 | 10.8 | 1.4 | 8.8 | 7.3 | 8.4 | 8.1 | 10.3 | 1.5 | 10.1 | 8.1 | 8.5 | 8.7 | 11.5 | 1.4 |
Larynx | 59.7 | 62.3 | 66.3 | 72.9 | 75.5 | 15.8 | 60.2 | 62.8 | 66.9 | 73.2 | 75.9 | 15.7 | 55.4 | 57.8 | 58.9 | 67.6 | 69.9 | 14.5 |
Lung | 11.3 | 12.7 | 16.5 | 20.1 | 26.7 | 15.4 | 10.4 | 11.6 | 15.2 | 17.9 | 22.7 | 12.3 | 14.2 | 16.2 | 20.1 | 25.8 | 35.8 | 21.6 |
Breast | 77.9 | 83.2 | 88.6 | 91.1 | 92.3 | 14.4 | 75.1 | 85.6 | 87.2 | 89.9 | 87.1 | 12.0 | 78.0 | 83.2 | 88.6 | 91.1 | 92.3 | 14.3 |
Cervix uteri | 77.5 | 80.0 | 81.4 | 80.5 | 79.9 | 2.4 | - | - | - | - | - | - | 77.5 | 80.0 | 81.4 | 80.5 | 79.9 | 2.4 |
Corpus uteri | 81.5 | 81.8 | 84.5 | 86.4 | 87.8 | 6.3 | - | - | - | - | - | - | 81.5 | 81.8 | 84.5 | 86.4 | 87.8 | 6.3 |
Ovary | 58.7 | 58.9 | 61.8 | 61.1 | 64.1 | 5.4 | - | - | - | - | - | - | 58.7 | 58.9 | 61.8 | 61.1 | 64.1 | 5.4 |
Prostate | 55.9 | 67.2 | 80.4 | 91.1 | 94.1 | 38.2 | 55.9 | 67.2 | 80.4 | 91.1 | 94.1 | 38.2 | - | - | - | - | - | - |
Testis | 85.4 | 90.4 | 90.7 | 93.1 | 95.6 | 10.2 | 85.4 | 90.4 | 90.7 | 93.1 | 95.6 | 10.2 | - | - | - | - | - | - |
Kidney | 62.0 | 66.1 | 73.6 | 78.4 | 82.2 | 20.2 | 60.8 | 64.4 | 73.0 | 78.2 | 81.6 | 20.8 | 64.5 | 69.7 | 74.7 | 78.8 | 83.6 | 19.1 |
Bladder | 69.1 | 73.1 | 75.7 | 76.7 | 75.8 | 6.7 | 70.0 | 74.8 | 77.5 | 78.8 | 77.8 | 7.8 | 65.5 | 66.3 | 68.8 | 68.6 | 67.7 | 2.2 |
Brain and CNS | 38.5 | 39.0 | 40.9 | 42.8 | 40.7 | 2.2 | 37.2 | 37.5 | 40.2 | 41.4 | 39.1 | 1.9 | 40.2 | 40.7 | 41.7 | 44.4 | 42.6 | 2.4 |
Thyroid | 94.2 | 94.9 | 98.4 | 99.9 | 100.3 | 6.1 | 87.2 | 89.5 | 96.0 | 100.1 | 100.6 | 13.4 | 95.4 | 95.9 | 98.7 | 99.9 | 100.2 | 4.8 |
Hodgkin lymphoma | 68.0 | 71.2 | 76.7 | 81.0 | 82.2 | 14.2 | 67.6 | 68.1 | 74.7 | 80.7 | 82.8 | 15.2 | 68.6 | 77.4 | 80.7 | 81.6 | 81.2 | 12.6 |
Non-Hodgkin lymphoma | 46.6 | 50.8 | 55.9 | 59.3 | 62.9 | 16.3 | 45.3 | 48.9 | 54.9 | 59.1 | 62.4 | 17.1 | 48.7 | 53.5 | 57.4 | 59.6 | 63.6 | 14.9 |
Multiple myeloma | 22.1 | 19.8 | 29.6 | 34.9 | 40.9 | 18.8 | 21.1 | 17.8 | 29.8 | 35.0 | 40.6 | 19.5 | 23.3 | 22.1 | 29.4 | 34.8 | 41.3 | 18.0 |
Leukemia | 26.5 | 33.3 | 42.0 | 47.6 | 51.0 | 24.5 | 26.2 | 32.3 | 41.8 | 46.8 | 51.1 | 24.9 | 26.8 | 34.6 | 42.2 | 48.6 | 50.8 | 24.0 |
Other and ill defined | 42.1 | 45.9 | 57.6 | 67.2 | 72.2 | 30.1 | 37.4 | 42.4 | 53.8 | 63.4 | 68.9 | 31.5 | 47.4 | 50.0 | 61.8 | 71.0 | 75.5 | 28.1 |
Site/Type |
Crude prevalence rate per 100,000a) |
Age-standardized prevalence rate per 100,000b) |
||||
---|---|---|---|---|---|---|
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 3,162.8 | 2,781.0 | 3,544.1 | 1,956.9 | 1,826.6 | 2,171.5 |
Lip, oral cavity, and pharynx | 42.8 | 57.6 | 28.1 | 26.8 | 37.9 | 17.2 |
Esophagus | 18.0 | 32.5 | 3.6 | 10.3 | 20.6 | 1.8 |
Stomach | 504.4 | 668.9 | 340.1 | 291.5 | 425.6 | 180.9 |
Colon and rectum | 433.1 | 516.8 | 349.4 | 248.2 | 330.6 | 181.7 |
Liver | 120.3 | 180.2 | 60.4 | 73.5 | 116.8 | 34.2 |
Gallbladderc) | 38.2 | 39.1 | 37.3 | 21.1 | 24.7 | 18.4 |
Pancreas | 18.7 | 19.8 | 17.6 | 11.1 | 12.9 | 9.7 |
Larynx | 19.7 | 37.1 | 2.3 | 11.2 | 23.6 | 1.2 |
Lung | 137.2 | 172.8 | 101.8 | 78.7 | 110.2 | 54.5 |
Breast | 351.5 | 2.7 | 699.8 | 221.7 | 1.7 | 435.9 |
Cervix uteri | 99.1 | - | 198.0 | 61.5 | - | 120.0 |
Corpus uteri | 40.9 | - | 81.8 | 26.1 | - | 51.2 |
Ovary | 35.5 | - | 71.0 | 24.2 | - | 48.1 |
Prostate | 136.3 | 272.8 | - | 71.3 | 170.0 | - |
Testis | 5.8 | 11.5 | - | 5.2 | 10.3 | - |
Kidney | 69.3 | 93.7 | 45.0 | 43.5 | 62.0 | 27.1 |
Bladder | 61.6 | 100.6 | 22.7 | 33.7 | 64.1 | 10.6 |
Brain and CNS | 20.3 | 21.0 | 19.7 | 17.2 | 18.3 | 16.1 |
Thyroid | 696.8 | 236.3 | 1,156.8 | 464.9 | 160.2 | 767.5 |
Hodgkin lymphoma | 5.0 | 6.4 | 3.7 | 4.2 | 5.1 | 3.2 |
Non-Hodgkin lymphoma | 53.9 | 61.4 | 46.5 | 38.2 | 45.9 | 31.1 |
Multiple myeloma | 10.5 | 10.9 | 10.0 | 6.1 | 7.0 | 5.4 |
Leukemia | 37.8 | 41.8 | 33.8 | 35.2 | 39.2 | 31.1 |
Other and ill defined | 205.9 | 197.1 | 214.6 | 131.4 | 139.9 | 124.4 |
CNS, central nervous system.
a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,
b) Age-adjusted using the Segi’s world standard population,
c) Includes the gallbladder and other/unspecified parts of the biliary tract.
Association Between lncRNA HULC rs7763881 Polymorphism and Gastric Cancer Risk
Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial
Site/Type | New cases |
Deaths |
Prevalent cases |
||||||
---|---|---|---|---|---|---|---|---|---|
Both sexes | Men | Women | Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 214,701 | 113,335 | 101,366 | 76,855 | 47,678 | 29,177 | 1,611,487 | 707,977 | 903,510 |
Lip, oral cavity, and pharynx | 3,309 | 2,390 | 919 | 1,170 | 884 | 286 | 21,827 | 14,656 | 7,171 |
Esophagus | 2,420 | 2,201 | 219 | 1,531 | 1,401 | 130 | 9,171 | 8,262 | 909 |
Stomach | 29,207 | 19,545 | 9,662 | 8,526 | 5,507 | 3,019 | 256,995 | 170,294 | 86,701 |
Colon and rectum | 26,790 | 15,911 | 10,879 | 8,301 | 4,698 | 3,603 | 220,653 | 131,579 | 89,074 |
Liver | 15,757 | 11,732 | 4,025 | 11,311 | 8,382 | 2,929 | 61,290 | 45,881 | 15,409 |
Gallbladder |
6,251 | 3,220 | 3,031 | 4,211 | 2,135 | 2,076 | 19,468 | 9,958 | 9,510 |
Pancreas | 6,342 | 3,359 | 2,983 | 5,439 | 2,908 | 2,531 | 9,517 | 5,031 | 4,486 |
Larynx | 1,146 | 1,079 | 67 | 344 | 319 | 25 | 10,049 | 9,452 | 597 |
Lung | 24,267 | 17,015 | 7,252 | 17,399 | 12,677 | 4,722 | 69,931 | 43,987 | 25,944 |
Breast | 19,219 | 77 | 19,142 | 2,354 | 16 | 2,338 | 179,081 | 686 | 178,395 |
Cervix uteri | 3,582 | - | 3,582 | 967 | - | 3,582 | 50,477 | - | 3,582 |
Corpus uteri | 2,404 | - | 2,404 | 319 | - | 2,404 | 20,859 | - | 2,404 |
Ovary | 2,443 | - | 2,443 | 1,055 | - | 2,443 | 18,112 | - | 2,443 |
Prostate | 10,212 | 10,212 | - | 1,700 | 1,700 | - | 69,438 | 69,438 | - |
Testis | 286 | 286 | - | 10 | 10 | - | 2,939 | 2,939 | - |
Kidney | 4,555 | 3,134 | 1,421 | 952 | 672 | 280 | 35,333 | 23,862 | 11,471 |
Bladder | 4,033 | 3,245 | 788 | 1,299 | 960 | 339 | 31,407 | 25,609 | 5,798 |
Brain and CNS | 1,776 | 958 | 818 | 1,266 | 674 | 592 | 10,349 | 5,334 | 5,015 |
Thyroid | 25,029 | 5,386 | 19,643 | 341 | 106 | 235 | 355,057 | 60,151 | 294,906 |
Hodgkin lymphoma | 271 | 174 | 97 | 49 | 33 | 16 | 2,571 | 1,623 | 948 |
Non-Hodgkin lymphoma | 4,396 | 2,519 | 1,877 | 1,771 | 1,026 | 745 | 27,478 | 15,622 | 11,856 |
Multiple myeloma | 1,455 | 762 | 693 | 889 | 466 | 423 | 5,330 | 2,779 | 2,551 |
Leukemia | 3,242 | 1,830 | 1,412 | 1,720 | 1,003 | 717 | 19,260 | 10,654 | 8,606 |
Other and ill defined | 16,309 | 8,300 | 8,009 | 3,931 | 2,101 | 1,830 | 104,895 | 50,180 | 54,715 |
Site/Type | Crude incidence rate per 100,000 |
Age-standardized incidence rate per 100,000 |
||||
---|---|---|---|---|---|---|
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 421.4 | 445.2 | 397.6 | 258.9 | 291.7 | 241.1 |
Lip, oral cavity, and pharynx | 6.5 | 9.4 | 3.6 | 4.1 | 6.2 | 2.2 |
Esophagus | 4.7 | 8.6 | 0.9 | 2.7 | 5.5 | 0.4 |
Stomach | 57.3 | 76.8 | 37.9 | 33.8 | 49.3 | 20.5 |
Colon and rectum | 52.6 | 62.5 | 42.7 | 30.4 | 40.2 | 22.2 |
Liver | 30.9 | 46.1 | 15.8 | 18.2 | 29.5 | 8.2 |
Gallbladder |
12.3 | 12.6 | 11.9 | 6.6 | 8.0 | 5.5 |
Pancreas | 12.4 | 13.2 | 11.7 | 7.0 | 8.5 | 5.7 |
Larynx | 2.2 | 4.2 | 0.3 | 1.3 | 2.7 | 0.1 |
Lung | 47.6 | 66.8 | 28.4 | 26.4 | 42.3 | 14.3 |
Breast | 37.7 | 0.3 | 75.1 | 24.8 | 0.2 | 49.2 |
Cervix uteri | 7.0 | - | 14.1 | 4.6 | - | 9.1 |
Corpus uteri | 4.7 | - | 9.4 | 3.1 | - | 6.1 |
Ovary | 4.8 | - | 9.6 | 3.2 | - | 6.3 |
Prostate | 20.0 | 40.1 | - | 11.2 | 25.4 | - |
Testis | 0.6 | 1.1 | - | 0.6 | 1.1 | - |
Kidney | 8.9 | 12.3 | 5.6 | 5.7 | 8.2 | 3.4 |
Bladder | 7.9 | 12.7 | 3.1 | 4.3 | 8.1 | 1.5 |
Brain and CNS | 3.5 | 3.8 | 3.2 | 2.8 | 3.1 | 2.4 |
Thyroid | 49.1 | 21.2 | 77.1 | 35.2 | 15.1 | 55.6 |
Hodgkin lymphoma | 0.5 | 0.7 | 0.4 | 0.5 | 0.6 | 0.4 |
Non-Hodgkin lymphoma | 8.6 | 9.9 | 7.4 | 5.9 | 7.2 | 4.6 |
Multiple myeloma | 2.9 | 3.0 | 2.7 | 1.6 | 1.9 | 1.4 |
Leukemia | 6.4 | 7.2 | 5.5 | 5.3 | 6.2 | 4.5 |
Other and ill defined | 32.0 | 32.6 | 31.4 | 19.7 | 22.6 | 17.4 |
Rank | Cause of death | No. of deaths (%) | Age-standardized death rate per 100,000 |
---|---|---|---|
All causes | 275,895 (100) | 289.3 | |
1 | Cancer | 76,855 (27.9) | 82.0 |
2 | Heart disease | 28,326 (10.3) | 27.9 |
3 | Cerebrovascular disease | 24,455 (8.9) | 23.4 |
4 | Pneumonia | 14,718 (5.3) | 13.5 |
5 | Intentional self-harm (suicide) | 13,513 (4.9) | 18.3 |
6 | Diabetes mellitus | 10,558 (3.8) | 10.2 |
7 | Chronic lower respiratory diseases | 7,538 (2.7) | 6.8 |
8 | Disease of liver | 6,847 (2.5) | 8.1 |
9 | Transport accidents | 5,539 (2.0) | 7.6 |
10 | Hypertensive diseases | 5,050 (1.8) | 4.6 |
Others | 82,496 (29.9) | 87.1 |
Site/Type | Crude mortality rate per 100,000 |
Age-standardized mortality rate per 100,000 |
||||
---|---|---|---|---|---|---|
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 150.8 | 187.3 | 114.4 | 82.0 | 119.6 | 54.6 |
Lip, oral cavity, and pharynx | 2.3 | 3.5 | 1.1 | 1.3 | 2.3 | 0.6 |
Esophagus | 3.0 | 5.5 | 0.5 | 1.6 | 3.4 | 0.2 |
Stomach | 16.7 | 21.6 | 11.8 | 8.9 | 13.8 | 5.4 |
Colon and rectum | 16.3 | 18.5 | 14.1 | 8.5 | 11.8 | 6.1 |
Liver | 22.2 | 32.9 | 11.5 | 12.6 | 20.9 | 5.4 |
Gallbladder |
8.3 | 8.4 | 8.1 | 4.2 | 5.3 | 3.4 |
Pancreas | 10.7 | 11.4 | 9.9 | 5.7 | 7.2 | 4.5 |
Larynx | 0.7 | 1.3 | 0.1 | 0.4 | 0.8 | 0.0 |
Lung | 34.1 | 49.8 | 18.5 | 17.9 | 31.2 | 8.2 |
Breast | 4.6 | 0.1 | 9.2 | 2.8 | 0.0 | 5.5 |
Cervix uteri | 1.9 | - | 3.8 | 1.1 | - | 2.0 |
Corpus uteri | 0.6 | - | 1.3 | 0.4 | - | 0.7 |
Ovary | 2.1 | - | 4.1 | 1.2 | - | 2.2 |
Prostate | 3.3 | 6.7 | - | 1.6 | 4.3 | - |
Testis | 0.0 | 0.0 | - | 0.0 | 0.0 | - |
Kidney | 1.9 | 2.6 | 1.1 | 1.0 | 1.7 | 0.5 |
Bladder | 2.5 | 3.8 | 1.3 | 1.2 | 2.4 | 0.5 |
Brain and CNS | 2.5 | 2.6 | 2.3 | 1.7 | 1.9 | 1.5 |
Thyroid | 0.7 | 0.4 | 0.9 | 0.3 | 0.3 | 0.4 |
Hodgkin lymphoma | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
Non-Hodgkin lymphoma | 3.5 | 4.0 | 2.9 | 2.0 | 2.7 | 1.4 |
Multiple myeloma | 1.7 | 1.8 | 1.7 | 1.0 | 1.2 | 0.8 |
Leukemia | 3.4 | 3.9 | 2.8 | 2.2 | 2.8 | 1.7 |
Other and ill defined | 7.7 | 8.3 | 7.2 | 4.3 | 5.5 | 3.5 |
Site/Type | Both sexes |
Men |
Women |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1999 | 2015 | Trend 1 |
Trend 2 |
1999 | 2015 | Trend 1 |
Trend 2 |
1999 | 2015 | Trend 1 |
Trend 2 |
|||||||
Year | APC | Year | APC | Year | APC | Year | APC | Year | APC | Year | APC | |||||||
All sites | 210.5 | 258.9 | 1999-2012 | 3.4 |
2012-2015 | –6.1 |
285.0 | 291.7 | 1999-2011 | 1.7 |
2011-2015 | –3.6 |
161.1 | 241.1 | 1999-2012 | 5.5 |
2012-2015 | –7.5 |
Lip, oral cavity, and pharynx | 3.6 | 4.1 | 1999-2015 | 0.5 |
- | - | 6.1 | 6.2 | 1999-2015 | –0.2 | - | - | 1.6 | 2.2 | 1999-2015 | 1.4 |
- | - |
Esophagus | 4.1 | 2.7 | 1999-2015 | –2.3 |
- | - | 8.8 | 5.5 | 1999-2015 | –2.7 |
- | - | 0.6 | 0.4 | 1999-2015 | –1.8 |
- | - |
Stomach | 43.6 | 33.8 | 1999-2011 | –0.1 | 2011-2015 | –5.7 |
66.2 | 49.3 | 1999-2011 | –0.3 | 2011-2015 | –6.2 |
26.7 | 20.5 | 1999-2011 | –0.3 | 2011-2015 | –5.1 |
Colon and rectum | 20.4 | 30.4 | 1999-2010 | 6.0 |
2010-2015 | –4.9 |
26.2 | 40.2 | 1999-2010 | 6.5 |
2010-2015 | –5.4 |
16.4 | 22.2 | 1999-2010 | 4.9 |
2010-2015 | –4.3 |
Liver | 27.9 | 18.2 | 1999-2010 | –1.7 |
2010-2015 | –4.6 |
46.8 | 29.5 | 1999-2009 | –1.9 |
2009-2015 | –4.2 |
12.3 | 8.2 | 1999-2010 | –1.5 |
2010-2015 | –5.0 |
Gallbladder |
6.5 | 6.6 | 1999-2004 | 1.5 | 2004-2015 | –0.3 | 8.1 | 8.0 | 1999-2015 | 0.0 | - | - | 5.4 | 5.5 | 1999-2003 | 2.5 | 2003-2015 | –0.6 |
Pancreas | 5.6 | 7.0 | 1999-2015 | 1.4 |
- | - | 7.8 | 8.5 | 1999-2015 | 0.7 |
- | - | 4.0 | 5.7 | 1999-2015 | 2.2 |
- | - |
Larynx | 2.3 | 1.3 | 1999-2015 | –3.6 |
- | - | 4.9 | 2.7 | 1999-2015 | –3.8 |
- | - | 0.4 | 0.1 | 1999-2007 | –8.9 |
2007-2015 | –4.2 |
Lung | 28.5 | 26.4 | 1999-2011 | 0.1 | 2011-2015 | –1.8 |
51.4 | 42.3 | 1999-2005 | –0.1 | 2005-2015 | –1.6 |
12.4 | 14.3 | 1999-2012 | 1.9 |
2012-2015 | –2.0 |
Breast | 10.7 | 24.8 | 1999-2007 | 6.9 |
2007-2015 | 4.0 |
0.2 | 0.2 | 1999-2015 | –1.1 | - | - | 20.9 | 49.2 | 1999-2007 | 7.1 |
2007-2015 | 4.1 |
Cervix uteri | 8.5 | 4.6 | 1999-2015 | –3.9 |
- | - | - | - | - | - | - | - | 16.3 | 9.1 | 1999-2015 | –3.7 |
- | - |
Corpus uteri | 1.4 | 3.1 | 1999-2009 | 6.2 |
2009-2015 | 3.1 |
- | - | - | - | - | - | 2.8 | 6.1 | 1999-2009 | 6.4 |
2009-2015 | 3.3 |
Ovary | 2.7 | 3.2 | 1999-2015 | 1.6 |
- | - | - | - | - | - | - | - | 5.0 | 6.3 | 1999-2015 | 1.8 |
- | - |
Prostate | 3.1 | 11.2 | 1999-2009 | 15.3 |
2009-2015 | 0.3 | 8.4 | 25.4 | 1999-2009 | 13.7 |
2009-2015 | –0.5 | - | - | - | - | - | - |
Testis | 0.3 | 0.6 | 1999-2015 | 4.9 |
- | - | 0.6 | 1.1 | 1999-2015 | 4.8 |
- | - | - | - | - | - | - | - |
Kidney | 3.0 | 5.7 | 1999-2009 | 6.7 |
2009-2015 | 1.3 |
4.5 | 8.2 | 1999-2010 | 6.1 |
2010-2015 | 0.4 | 1.7 | 3.4 | 1999-2009 | 6.6 |
2009-2015 | 1.1 |
Bladder | 4.6 | 4.3 | 1999-2004 | 2.4 |
2004-2015 | –1.5 |
9.0 | 8.1 | 1999-2005 | 1.5 |
2005-2015 | –1.8 |
1.6 | 1.5 | 1999-2003 | 2.6 | 2003-2015 | –1.7 |
Brain and CNS | 2.9 | 2.8 | 1999-2008 | 1.3 |
2008-2015 | –1.6 |
3.2 | 3.1 | 1999-2009 | 1.2 |
2009-2015 | –2.0 | 2.6 | 2.4 | 1999-2007 | 1.5 | 2007-2015 | –1.5 |
Thyroid | 6.3 | 35.2 | 1999-2011 | 22.8 |
2011-2015 | –13.3 |
2.1 | 15.1 | 1999-2012 | 22.9 |
2012-2015 | –16.9 |
10.4 | 55.6 | 1999-2011 | 22.4 |
2011-2015 | –14.4 |
Hodgkin lymphoma | 0.2 | 0.5 | 1999-2015 | 4.1 |
- | - | 0.4 | 0.6 | 1999-2015 | 3.2 |
- | - | 0.1 | 0.4 | 1999-2015 | 5.3 |
- | - |
Non-Hodgkin lymphoma | 4.3 | 5.9 | 1999-2015 | 2.3 |
- | - | 5.6 | 7.2 | 1999-2015 | 1.9 |
- | - | 3.3 | 4.6 | 1999-2015 | 2.6 |
- | - |
Multiple myeloma | 1.0 | 1.6 | 1999-2015 | 3.3 |
- | - | 1.2 | 1.9 | 1999-2015 | 3.0 |
- | - | 0.8 | 1.4 | 1999-2015 | 3.5 |
- | - |
Leukemia | 4.7 | 5.3 | 1999-2015 | 0.9 |
- | - | 5.5 | 6.2 | 1999-2015 | 1.0 |
- | - | 3.9 | 4.5 | 1999-2015 | 0.7 |
- | - |
Other and ill defined | 14.4 | 19.7 | 1999-2008 | 3.5 |
2008-2015 | 1.3 |
18.1 | 22.6 | 1999-2015 | 1.8 |
- | - | 11.9 | 17.4 | 1999-2011 | 3.8 |
2011-2015 | –0.3 |
Site/Type | Both sexes |
Men |
Women |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1999 | 2015 | Trend 1 |
Trend 2 |
1999 | 2015 | Trend 1 |
Trend 2 |
1999 | 2015 | Trend 1 |
Trend 2 |
|||||||
Year | APC | Year | APC | Year | APC | Year | APC | Year | APC | Year | APC | |||||||
All sites | 114.3 | 82.0 | 1999-2002 | 1.0 | 2002-2015 | –2.7 |
176.6 | 119.6 | 1999-2002 | 1.2 | 2002-2015 | –3.1 |
70.6 | 54.6 | 1999-2002 | 1.0 | 2002-2015 | –2.2 |
Lip, oral cavity, and pharynx | 1.1 | 1.3 | 1999-2015 | –1.8 |
- | - | 2.0 | 2.3 | 1999-2015 | –2.1 |
- | - | 0.4 | 0.6 | 1999-2015 | –2.7 |
- | - |
Esophagus | 3.1 | 1.6 | 1999-2015 | –4.4 |
- | - | 6.8 | 3.4 | 1999-2015 | –4.6 |
- | - | 0.5 | 0.2 | 1999-2015 | –5.1 |
- | - |
Stomach | 23.8 | 8.9 | 1999-2003 | –3.3 |
2003-2015 | –6.7 |
36.9 | 13.8 | 1999-2003 | –2.6 |
2003-2015 | –7.0 |
14.6 | 5.4 | 1999-2003 | –4.4 |
2003-2015 | –6.6 |
Colon and rectum | 7.7 | 8.5 | 1999-2004 | 5.5 |
2004-2015 | –1.3 |
10.5 | 11.8 | 1999-2004 | 5.9 |
2004-2015 | –1.0 |
6.0 | 6.1 | 1999-2004 | 4.9 |
2004-2015 | –1.8 |
Liver | 20.4 | 12.6 | 1999-2002 | 0.8 | 2002-2015 | –3.6 |
35.3 | 20.9 | 1999-2002 | –0.1 | 2002-2015 | –3.7 |
8.3 | 5.4 | 1999-2002 | 2.9 | 2002-2015 | –3.7 |
Gallbladder |
5.2 | 4.2 | 1999-2001 | 7.4 | 2001-2015 | –2.7 |
6.8 | 5.3 | 1999-2001 | 6.2 | 2001-2015 | –2.8 |
4.1 | 3.4 | 1999-2001 | 9.2 | 2001-2015 | –2.6 |
Pancreas | 5.4 | 5.7 | 1999-2015 | 0.3 |
- | - | 7.6 | 7.2 | 1999-2015 | –0.4 |
- | - | 3.9 | 4.5 | 1999-2015 | 0.9 |
- | - |
Larynx | 1.6 | 0.4 | 1999-2015 | –9.5 |
- | - | 3.4 | 0.8 | 1999-2015 | –9.1 |
- | - | 0.4 | 0.0 | 1999-2010 | –15.4 |
2010-2015 | –6.2 |
Lung | 22.4 | 17.9 | 1999-2002 | 1.8 | 2002-2015 | –2.1 |
41.5 | 31.2 | 1999-2001 | 4.3 | 2001-2015 | –2.5 |
9.4 | 8.2 | 1999-2002 | 2.3 | 2002-2015 | –1.5 |
Breast | 2.2 | 2.8 | 1999-2015 | 1.4 |
- | - | 0.1 | 0.0 | 1999-2015 | –4.5 |
- | - | 4.2 | 5.5 | 1999-2015 | 1.7 |
- | - |
Cervix uteri | 1.4 | 1.1 | 1999-2003 | 8.4 |
2003-2015 | –5.2 |
- | - | - | - | - | - | 2.6 | 2.0 | 1999-2003 | 7.8 |
2003-2015 | –4.9 |
Corpus uteri | 0.1 | 0.4 | 1999-2002 | 51.8 |
2002-2015 | 3.4 |
- | - | - | - | - | - | 0.1 | 0.7 | 1999-2002 | 51.6 |
2002-2015 | 3.8 |
Ovary | 0.9 | 1.2 | 1999-2001 | 10.9 | 2001-2015 | 0.2 | - | - | - | - | - | - | 1.7 | 2.2 | 1999-2001 | 10.2 | 2001-2015 | 0.5 |
Prostate | 0.9 | 1.6 | 1999-2004 | 9.4 |
2004-2015 | 0.4 | 2.6 | 4.3 | 1999-2002 | 17.5 |
2002-2015 | 0.3 | - | - | - | - | - | - |
Testis | 0.0 | 0.0 | 1999-2015 | –2.5 | - | - | 0.1 | 0.0 | 1999-2015 | 2.9 | - | - | - | - | - | - | - | - |
Kidney | 1.1 | 1.0 | 1999-2015 | –0.1 | - | - | 1.8 | 1.7 | 1999-2015 | 0.0 | - | - | 0.5 | 0.5 | 1999-2015 | –0.8 | - | - |
Bladder | 1.3 | 1.2 | 1999-2015 | –1.3 |
- | - | 2.6 | 2.4 | 1999-2015 | –1.6 |
- | - | 0.5 | 0.5 | 1999-2001 | 10.8 | 2001-2015 | –1.9 |
Brain and CNS | 1.9 | 1.7 | 1999-2002 | 4.4 | 2002-2015 | –2.0 |
2.2 | 1.9 | 1999-2015 | –1.5 |
- | - | 1.6 | 1.5 | 1999-2015 | –1.4 |
- | - |
Thyroid | 0.4 | 0.3 | 1999-2003 | 7.0 | 2003-2015 | –4.2 |
0.3 | 0.3 | 1999-2002 | 16.0 | 2002-2015 | –4.0 |
0.5 | 0.4 | 1999-2004 | 4.3 | 2004-2015 | –4.7 |
Hodgkin lymphoma | 0.0 | 0.1 | 1999-2003 | 29.6 | 2003-2015 | –0.2 | 0.0 | 0.1 | 1999-2004 | 19.2 |
2004-2015 | –2.0 | 0.0 | 0.0 | 1999-2003 | 40.8 | 2003-2015 | 1.3 |
Non-Hodgkin lymphoma | 2.1 | 2.0 | 1999-2015 | –0.5 |
- | - | 3.0 | 2.7 | 1999-2015 | –0.8 |
- | - | 1.4 | 1.4 | 1999-2015 | –0.2 | - | - |
Multiple myeloma | 0.6 | 1.0 | 1999-2003 | 12.8 |
2003-2015 | 0.8 | 0.8 | 1.2 | 1999-2003 | 10.9 |
2003-2015 | 0.8 | 0.4 | 0.8 | 1999-2007 | 7.4 |
2007-2015 | –1.1 |
Leukemia | 2.9 | 2.2 | 1999-2001 | 1.4 | 2001-2015 | –2.1 |
3.5 | 2.8 | 1999-2015 | –1.7 |
- | - | 2.4 | 1.7 | 1999-2015 | –2.1 |
- | - |
Other and ill defined | 7.8 | 4.3 | 1999-2015 | –3.1 |
- | - | 9.0 | 5.5 | 1999-2009 | –0.6 | 2009-2015 | –6.8 |
7.0 | 3.5 | 1999-2005 | –7.0 |
2005-2015 | –2.2 |
Rank | Age (yr) |
|||
---|---|---|---|---|
0-14 | 15-34 | 35-64 | ≥ 65 | |
Men | ||||
1 | Leukemia (4.7) | Thyroid (11.9) | Stomach (81.9) | Lung (436.0) |
2 | Non-Hodgkin lymphoma (2.7) | Leukemia (3.8) | Colon and rectum (62.9) | Stomach (353.5) |
3 | Brain and CNS (1.9) | Non-Hodgkin lymphoma (2.8) | Liver (56.9) | Colon and rectum (300.4) |
4 | Kidney (0.5) | Colon and rectum (2.7) | Lung (42.1) | Prostate (284.2) |
5 | Liver (0.4) | Testis (2.3) | Thyroid (33.7) | Liver (178.7) |
Women | ||||
1 | Leukemia (4.1) | Thyroid (45.9) | Breast (132.5) | Colon and rectum (168.4) |
2 | Brain and CNS (1.6) | Breast (10.9) | Thyroid (125.6) | Stomach (137.0) |
3 | Non-Hodgkin lymphoma (1.5) | Cervix uteri (5.2) | Colon and rectum (37.0) | Lung (122.1) |
4 | Thyroid (0.9) | Ovary (3.0) | Stomach (36.5) | Breast (78.2) |
5 | Ovary (0.6) | Stomach (2.9) | Lung (21.9) | Live (66.3) |
Site/Type | Both sexes |
Men |
Women |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1993-1995 | 1996-2000 | 2001-2005 | 2006-2010 | 2011-2015 | Change |
1993-1995 | 1996-2000 | 2001-2005 | 2006-2010 | 2011-2015 | Change |
1993-1995 | 1996-2000 | 2001-2005 | 2006-2010 | 2011-2015 | Change |
|
All sites | 41.2 | 44.0 | 54.0 | 65.2 | 70.7 | 29.5 | 31.7 | 35.3 | 45.4 | 56.5 | 62.8 | 31.1 | 53.4 | 55.3 | 64.2 | 74.2 | 78.4 | 25.0 |
Lip, oral cavity, and pharynx | 41.1 | 46.7 | 54.3 | 60.6 | 64.5 | 23.4 | 35.8 | 41.1 | 49.4 | 56.4 | 60.7 | 24.9 | 58.1 | 63.8 | 67.8 | 71.7 | 74.1 | 16.0 |
Esophagus | 12.7 | 15.2 | 21.4 | 29.6 | 36.0 | 23.3 | 11.8 | 14.3 | 20.6 | 29.0 | 35.7 | 23.9 | 23.7 | 24.2 | 29.7 | 36.5 | 39.3 | 15.6 |
Stomach | 42.8 | 46.6 | 57.8 | 68.1 | 75.4 | 32.6 | 43.0 | 46.9 | 58.4 | 68.7 | 76.3 | 33.3 | 42.6 | 46.0 | 56.5 | 66.7 | 73.7 | 31.1 |
Colon and rectum | 54.8 | 58.0 | 66.7 | 73.5 | 76.3 | 21.5 | 55.3 | 59.0 | 68.5 | 75.4 | 78.0 | 22.7 | 54.2 | 56.8 | 64.3 | 70.8 | 73.6 | 19.4 |
Liver | 10.7 | 13.2 | 20.4 | 28.1 | 33.6 | 22.9 | 9.9 | 12.9 | 20.3 | 28.1 | 34.1 | 24.2 | 13.6 | 14.2 | 20.9 | 28.1 | 32.2 | 18.6 |
Gallbladder |
17.3 | 19.7 | 23.1 | 26.8 | 29.1 | 11.8 | 16.6 | 20.3 | 23.5 | 27.7 | 30.2 | 13.6 | 18.0 | 19.1 | 22.7 | 25.9 | 28.0 | 10.0 |
Pancreas | 9.4 | 7.6 | 8.4 | 8.4 | 10.8 | 1.4 | 8.8 | 7.3 | 8.4 | 8.1 | 10.3 | 1.5 | 10.1 | 8.1 | 8.5 | 8.7 | 11.5 | 1.4 |
Larynx | 59.7 | 62.3 | 66.3 | 72.9 | 75.5 | 15.8 | 60.2 | 62.8 | 66.9 | 73.2 | 75.9 | 15.7 | 55.4 | 57.8 | 58.9 | 67.6 | 69.9 | 14.5 |
Lung | 11.3 | 12.7 | 16.5 | 20.1 | 26.7 | 15.4 | 10.4 | 11.6 | 15.2 | 17.9 | 22.7 | 12.3 | 14.2 | 16.2 | 20.1 | 25.8 | 35.8 | 21.6 |
Breast | 77.9 | 83.2 | 88.6 | 91.1 | 92.3 | 14.4 | 75.1 | 85.6 | 87.2 | 89.9 | 87.1 | 12.0 | 78.0 | 83.2 | 88.6 | 91.1 | 92.3 | 14.3 |
Cervix uteri | 77.5 | 80.0 | 81.4 | 80.5 | 79.9 | 2.4 | - | - | - | - | - | - | 77.5 | 80.0 | 81.4 | 80.5 | 79.9 | 2.4 |
Corpus uteri | 81.5 | 81.8 | 84.5 | 86.4 | 87.8 | 6.3 | - | - | - | - | - | - | 81.5 | 81.8 | 84.5 | 86.4 | 87.8 | 6.3 |
Ovary | 58.7 | 58.9 | 61.8 | 61.1 | 64.1 | 5.4 | - | - | - | - | - | - | 58.7 | 58.9 | 61.8 | 61.1 | 64.1 | 5.4 |
Prostate | 55.9 | 67.2 | 80.4 | 91.1 | 94.1 | 38.2 | 55.9 | 67.2 | 80.4 | 91.1 | 94.1 | 38.2 | - | - | - | - | - | - |
Testis | 85.4 | 90.4 | 90.7 | 93.1 | 95.6 | 10.2 | 85.4 | 90.4 | 90.7 | 93.1 | 95.6 | 10.2 | - | - | - | - | - | - |
Kidney | 62.0 | 66.1 | 73.6 | 78.4 | 82.2 | 20.2 | 60.8 | 64.4 | 73.0 | 78.2 | 81.6 | 20.8 | 64.5 | 69.7 | 74.7 | 78.8 | 83.6 | 19.1 |
Bladder | 69.1 | 73.1 | 75.7 | 76.7 | 75.8 | 6.7 | 70.0 | 74.8 | 77.5 | 78.8 | 77.8 | 7.8 | 65.5 | 66.3 | 68.8 | 68.6 | 67.7 | 2.2 |
Brain and CNS | 38.5 | 39.0 | 40.9 | 42.8 | 40.7 | 2.2 | 37.2 | 37.5 | 40.2 | 41.4 | 39.1 | 1.9 | 40.2 | 40.7 | 41.7 | 44.4 | 42.6 | 2.4 |
Thyroid | 94.2 | 94.9 | 98.4 | 99.9 | 100.3 | 6.1 | 87.2 | 89.5 | 96.0 | 100.1 | 100.6 | 13.4 | 95.4 | 95.9 | 98.7 | 99.9 | 100.2 | 4.8 |
Hodgkin lymphoma | 68.0 | 71.2 | 76.7 | 81.0 | 82.2 | 14.2 | 67.6 | 68.1 | 74.7 | 80.7 | 82.8 | 15.2 | 68.6 | 77.4 | 80.7 | 81.6 | 81.2 | 12.6 |
Non-Hodgkin lymphoma | 46.6 | 50.8 | 55.9 | 59.3 | 62.9 | 16.3 | 45.3 | 48.9 | 54.9 | 59.1 | 62.4 | 17.1 | 48.7 | 53.5 | 57.4 | 59.6 | 63.6 | 14.9 |
Multiple myeloma | 22.1 | 19.8 | 29.6 | 34.9 | 40.9 | 18.8 | 21.1 | 17.8 | 29.8 | 35.0 | 40.6 | 19.5 | 23.3 | 22.1 | 29.4 | 34.8 | 41.3 | 18.0 |
Leukemia | 26.5 | 33.3 | 42.0 | 47.6 | 51.0 | 24.5 | 26.2 | 32.3 | 41.8 | 46.8 | 51.1 | 24.9 | 26.8 | 34.6 | 42.2 | 48.6 | 50.8 | 24.0 |
Other and ill defined | 42.1 | 45.9 | 57.6 | 67.2 | 72.2 | 30.1 | 37.4 | 42.4 | 53.8 | 63.4 | 68.9 | 31.5 | 47.4 | 50.0 | 61.8 | 71.0 | 75.5 | 28.1 |
Site/Type | Crude prevalence rate per 100,000 |
Age-standardized prevalence rate per 100,000 |
||||
---|---|---|---|---|---|---|
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 3,162.8 | 2,781.0 | 3,544.1 | 1,956.9 | 1,826.6 | 2,171.5 |
Lip, oral cavity, and pharynx | 42.8 | 57.6 | 28.1 | 26.8 | 37.9 | 17.2 |
Esophagus | 18.0 | 32.5 | 3.6 | 10.3 | 20.6 | 1.8 |
Stomach | 504.4 | 668.9 | 340.1 | 291.5 | 425.6 | 180.9 |
Colon and rectum | 433.1 | 516.8 | 349.4 | 248.2 | 330.6 | 181.7 |
Liver | 120.3 | 180.2 | 60.4 | 73.5 | 116.8 | 34.2 |
Gallbladder |
38.2 | 39.1 | 37.3 | 21.1 | 24.7 | 18.4 |
Pancreas | 18.7 | 19.8 | 17.6 | 11.1 | 12.9 | 9.7 |
Larynx | 19.7 | 37.1 | 2.3 | 11.2 | 23.6 | 1.2 |
Lung | 137.2 | 172.8 | 101.8 | 78.7 | 110.2 | 54.5 |
Breast | 351.5 | 2.7 | 699.8 | 221.7 | 1.7 | 435.9 |
Cervix uteri | 99.1 | - | 198.0 | 61.5 | - | 120.0 |
Corpus uteri | 40.9 | - | 81.8 | 26.1 | - | 51.2 |
Ovary | 35.5 | - | 71.0 | 24.2 | - | 48.1 |
Prostate | 136.3 | 272.8 | - | 71.3 | 170.0 | - |
Testis | 5.8 | 11.5 | - | 5.2 | 10.3 | - |
Kidney | 69.3 | 93.7 | 45.0 | 43.5 | 62.0 | 27.1 |
Bladder | 61.6 | 100.6 | 22.7 | 33.7 | 64.1 | 10.6 |
Brain and CNS | 20.3 | 21.0 | 19.7 | 17.2 | 18.3 | 16.1 |
Thyroid | 696.8 | 236.3 | 1,156.8 | 464.9 | 160.2 | 767.5 |
Hodgkin lymphoma | 5.0 | 6.4 | 3.7 | 4.2 | 5.1 | 3.2 |
Non-Hodgkin lymphoma | 53.9 | 61.4 | 46.5 | 38.2 | 45.9 | 31.1 |
Multiple myeloma | 10.5 | 10.9 | 10.0 | 6.1 | 7.0 | 5.4 |
Leukemia | 37.8 | 41.8 | 33.8 | 35.2 | 39.2 | 31.1 |
Other and ill defined | 205.9 | 197.1 | 214.6 | 131.4 | 139.9 | 124.4 |
CNS, central nervous system. Limited-duration prevalent cases on January 1, 2016. These are patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times, Include the gallbladder and other/unspecified parts of the biliary tract.
CNS, central nervous system. Age-adjusted using the Segi’s world standard population, Includes the gallbladder and other/unspecified parts of the biliary tract.
Source: Mortality Data, 2015, Statistics Korea [ Age-adjusted using the Segi’s world standard population.
CNS, central nervous system. Age-adjusted using the world standard population, Includes the gallbladder and other/unspecified parts of the biliary tract.
APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system. Significantly different from zero (p < 0.05), Includes the gallbladder and other/unspecified parts of the biliary tract.
APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system. Significantly different from zero (p < 0.05), Includes the gallbladder and other/unspecified parts of the biliary tract.
CNS, central nervous system.
CNS, central nervous system. Percentage change in 5-year relative survival from 1993 to 1995 and 2011 to 2015, Includes the gallbladder and other/unspecified parts of the biliary tract.
CNS, central nervous system. Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times, Age-adjusted using the Segi’s world standard population, Includes the gallbladder and other/unspecified parts of the biliary tract.